glp 1 approval With FDA of Wegovy pill, new era of oral GLP-1 weight loss drugs begins Wegovy Pill Wins FDA Approval

Relative contraindications requiring careful consideration and enhanced medical supervision include history of pancreatitis, severe gastrointestinal disease including gastroparesis, diabetic retinopathy (requires ophthalmologic monitoring during therapy), severe kidney disease, history of suicidal ideation or severe depression, gallbladder disease or history of cholecystitis, and age under 18 years

Aim for 1.2-1.6 grams of protein per kilogram of body weight at minimum

164 : 62876295 Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H and Nakashima Y (2000) A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system

Let's dive in